Hospital
Carthage Area Hospital, INC.
Carthage Area Hospital, INC. was paid $16.07M by Medicaid between Oct 2019 and Dec 2024, across 150 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoCARTHAGE AREA HOSPITAL, INC.
CARTHAGE, NY 13619
CARTHAGE, NY 13619
33aNPI1104234376assigned 07/31/2014
33bProvider typeCritical Access Hospital
28Total paid$16.07M
24GClaims127,335
24DCodes billed150
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in New York
Rank by total paid#2 of 12
Median peer was paid$5.23M
This provider vs. median3.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 329 | $5K | |
| 2020 | 1,043 | $23K | |
| 2021 | 30,886 | $1.64M | |
| 2022 | 35,518 | $5.60M | |
| 2023 | 37,841 | $6.17M | |
| 2024incomplete | 21,718 | $2.64M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 23,443 | 21,183 | $3.98M |
| 36415 | Collection of venous blood by venipuncture | 7.9% | 14,165 | 9,118 | $1.27M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.0% | 4,835 | 4,523 | $1.13M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.0% | 3,741 | 3,604 | $968K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.1% | 3,588 | 3,448 | $656K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.9% | 3,048 | 2,862 | $619K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.8% | 5,115 | 4,929 | $619K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3.6% | 3,470 | 1,181 | $580K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.6% | 1,689 | 1,505 | $573K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.6% | 1,532 | 1,524 | $418K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.6% | 3,607 | 3,346 | $415K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.4% | 1,597 | 1,466 | $379K |
138 more codes
| 99285 | Emergency room visit (most serious) | 2.0% | 2,509 | $322K |
| 80053 | Comprehensive metabolic panel | 1.9% | 7,081 | $312K |
| 99000 | 1.6% | 1,025 | $264K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.5% | 760 | $244K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.5% | 1,231 | $241K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 756 | $233K |
| 41899 | Unlisted procedure, dentoalveolar structures | 1.4% | 116 | $222K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.2% | 614 | $197K |
| 81025 | 1.1% | 1,204 | $185K | |
| 92551 | 1.1% | 1,120 | $173K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.0% | 791 | $163K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,148 | $152K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,612 | $144K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 320 | $141K |
| 96160 | <1% | 719 | $130K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,379 | $124K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 938 | $118K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 242 | $97K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 722 | $79K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 617 | $74K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 426 | $74K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 895 | $49K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 288 | $47K |
| 41115 | <1% | 13 | $45K | |
| 90686 | <1% | 483 | $40K | |
| 87486 | <1% | 126 | $35K | |
| 88142 | <1% | 257 | $32K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 980 | $31K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,837 | $28K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 76 | $27K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 98 | $27K |
| 80061 | Lipid panel | <1% | 2,488 | $25K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 389 | $23K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 939 | $20K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 364 | $20K |
| 11056 | <1% | 620 | $19K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,140 | $18K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 102 | $16K |
| 90715 | <1% | 162 | $14K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,630 | $13K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 257 | $12K |
| 90656 | <1% | 101 | $11K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 43 | $10K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 81 | $9K |
| 86850 | <1% | 162 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 876 | $9K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,098 | $9K |
| 90647 | <1% | 88 | $9K | |
| 84439 | <1% | 1,024 | $8K | |
| 93015 | <1% | 16 | $8K | |
| 90723 | <1% | 98 | $7K | |
| 97161 | <1% | 78 | $7K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 33 | $7K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,134 | $7K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 49 | $7K |
| 99382 | <1% | 29 | $7K | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 807 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 348 | $6K |
| 90670 | <1% | 178 | $6K | |
| 99383 | <1% | 35 | $6K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 232 | $5K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 13 | $5K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 34 | $4K |
| 83880 | <1% | 114 | $4K | |
| 85027 | <1% | 1,251 | $4K | |
| 87800 | <1% | 25 | $4K | |
| 86900 | <1% | 86 | $4K | |
| 90633 | <1% | 37 | $3K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 25 | $3K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 28 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 71 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 13 | $3K |
| 87581 | <1% | 126 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 190 | $2K |
| 97803 | <1% | 13 | $2K | |
| 99001 | <1% | 114 | $2K | |
| 82652 | <1% | 51 | $2K | |
| 81015 | <1% | 988 | $2K | |
| 82607 | <1% | 200 | $2K | |
| 99173 | <1% | 38 | $2K | |
| 90671 | <1% | 27 | $2K | |
| 97802 | <1% | 12 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 80 | $2K |
| 86141 | <1% | 222 | $2K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 162 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 119 | $1K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 13 | $1K |
| 76801 | <1% | 13 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 200 | $1K |
| 82728 | <1% | 90 | $852.49 | |
| 83735 | <1% | 286 | $806.84 | |
| 86901 | <1% | 85 | $724.24 | |
| 11721 | <1% | 24 | $644.04 | |
| 90710 | <1% | 12 | $600.20 | |
| 85651 | <1% | 229 | $425.17 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 27 | $384.65 |
| 84481 | <1% | 39 | $359.70 | |
| 83655 | <1% | 25 | $331.56 | |
| 86038 | <1% | 59 | $293.20 | |
| 87186 | <1% | 115 | $288.80 | |
| 86618 | <1% | 15 | $237.92 | |
| 71045 | Radiologic examination, chest; single view | <1% | 115 | $232.69 |
| 81003 | <1% | 245 | $228.75 | |
| 86431 | <1% | 46 | $226.26 | |
| 90681 | <1% | 12 | $214.20 | |
| 87102 | <1% | 87 | $210.49 | |
| 84550 | <1% | 49 | $181.29 | |
| 86780 | <1% | 13 | $164.32 | |
| 85730 | <1% | 87 | $157.73 | |
| 87340 | <1% | 15 | $154.95 | |
| 86803 | <1% | 15 | $150.10 | |
| 84702 | <1% | 52 | $123.70 | |
| 84181 | <1% | 12 | $115.80 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 22 | $88.91 |
| 81002 | <1% | 151 | $88.20 | |
| 80361 | <1% | 14 | $81.78 | |
| 83550 | <1% | 25 | $80.83 | |
| 82746 | <1% | 13 | $80.38 | |
| 80365 | <1% | 14 | $71.67 | |
| 80346 | <1% | 14 | $70.38 | |
| 80324 | <1% | 14 | $70.38 | |
| 80348 | <1% | 14 | $68.34 | |
| 80358 | <1% | 14 | $68.34 | |
| 80353 | <1% | 14 | $68.34 | |
| 80359 | <1% | 14 | $68.34 | |
| 84703 | <1% | 106 | $58.00 | |
| 83605 | <1% | 232 | $55.80 | |
| 82550 | <1% | 12 | $55.33 | |
| 82043 | <1% | 13 | $55.17 | |
| 83690 | <1% | 311 | $47.10 | |
| 85610 | <1% | 12 | $47.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 241 | $41.44 |
| 84484 | <1% | 155 | $32.20 | |
| 73610 | <1% | 12 | $25.00 | |
| 73630 | 0% | 12 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 43 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 13 | $0.00 |
| 87040 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDUVALL, RICHARD (CEO ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Carthage Area Hospital INC | Carthage, NY | $9.61M |
| Carthage Area Hospital INC. | Carthage, NY | $2.66M |
| Carthage Area Hospital, INC. | Carthage, NY | $669K |
| Carthage Area Hospital INC | Carthage, NY | $227K |
| Carthage Area Hospital INC | Carthage, NY | $221K |
| Carthage Area Hospital, INC. | Lafargeville, NY | $74K |
| Carthage Area Hospital INC | Beaver Falls, NY | $58K |
| Claxton-Hepburn Medical Center | Ogdensburg, NY | $24K |
| Carthage Area Hospital INC | Philadelphia, NY | $5K |
| Claxton-Hepburn Medical Center | Canton, NY | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.